"Philippines in talks to procure 30M doses of Covovax vaccine"
Talks are ongoing for the Philippines to secure some 30 million doses of the Covovax vaccine against COVID-19, which is currently in its third stage of clinical trials, the local procurement partner said Sunday.
The vaccine is set to be manufactured by the Serum Institute of India (SII), which has partnered with the Faberco Life Sciences -- headed by Dr. Luningning Villa as medical director -- as its Philippine partner.
The candidate vaccine underwent the initial phases of the clinical trials in Australia, South Africa, and India, with the third phase of trials currently being carried out in the United Kingdom with 15,000 subjects, and in the United States and Mexico with 30,000 subjects.
"'Yun po ang nakikita po natin, na karamihan po sa mga ating pirmahan ay pinipilit po namin magkaroon kami ng initial success this December and mostly mga January," he said on December 14.
The Philippines has already allocated P73.2 billion for the procurement of the vaccines, with P40 billion coming from multilateral agencies, P20 billion from domestic sources, and P13.2 billion from bilateral agreements.
"Philippines in talks to procure 30M doses of Covovax vaccine"
Talks are ongoing for the Philippines to secure some 30 million doses of the Covovax vaccine against COVID-19, which is currently in its third stage of clinical trials, the local procurement partner said Sunday.
The vaccine is set to be manufactured by the Serum Institute of India (SII), which has partnered with the Faberco Life Sciences -- headed by Dr. Luningning Villa as medical director -- as its Philippine partner.
"'Yun po ang nakikita po natin, na karamihan po sa mga ating pirmahan ay pinipilit po namin magkaroon kami ng initial success this December and mostly mga January," he said on December 14.